The Systemic Synuclein Sampling Study: Toward a biomarker for Parkinson's disease

Naomi P. Visanji, Brit Mollenhauer, Thomas G. Beach, Charles Howard Adler, Christopher S. Coffey, Catherine M. Kopil, Kuldip D. Dave, Tatiana Foroud, Lana Chahine, Danna Jennings

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

The search for a biomarker for Parkinson's disease (PD) has led to a surge in literature describing peripheral α-synuclein (aSyn) in both biofluids and biopsy/autopsy tissues. Despite encouraging results, attempts to capitalize on this promise have fallen woefully short. The Systemic Synuclein Sampling Study (S4) is uniquely designed to identify a reproducible diagnostic and progression biomarker for PD. S4 will evaluate aSyn in multiple tissues and biofluids within the same subject and across the disease spectrum to identify the optimal biomarker source and provide vital information on the evolution of peripheral aSyn throughout the disease. Additionally, S4 will correlate the systemic aSyn profile with an objective measure of nigrostriatal dopaminergic function furthering our understanding of the pathophysiological progression of PD.

Original languageEnglish (US)
Pages (from-to)359-368
Number of pages10
JournalBiomarkers in Medicine
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2017

Keywords

  • Biofluid
  • Biomarker
  • Parkinson's disease
  • Tissue
  • α-synuclein

ASJC Scopus subject areas

  • Drug Discovery
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'The Systemic Synuclein Sampling Study: Toward a biomarker for Parkinson's disease'. Together they form a unique fingerprint.

Cite this